• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Management of diabetes in patients with COVID-19 - Authors' reply.2019冠状病毒病患者的糖尿病管理——作者回复
Lancet Diabetes Endocrinol. 2020 Aug;8(8):669-670. doi: 10.1016/S2213-8587(20)30223-0.
2
Antihypertensive drugs and risk of COVID-19? - Authors' reply.抗高血压药物与2019冠状病毒病风险？——作者回复
Lancet Respir Med. 2020 May;8(5):e32-e33. doi: 10.1016/S2213-2600(20)30159-4. Epub 2020 Mar 26.
3
Letter: SARS-CoV-2 induced gastrointestinal inflammation-authors' reply.信件：SARS-CoV-2 诱导的胃肠道炎症——作者的回复。
Aliment Pharmacol Ther. 2020 Dec;52(11-12):1750-1751. doi: 10.1111/apt.16117.
4
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):666-667. doi: 10.1016/S2213-8587(20)30231-X.
5
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):667-668. doi: 10.1016/S2213-8587(20)30227-8.
6
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):666. doi: 10.1016/S2213-8587(20)30226-6.
7
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):668. doi: 10.1016/S2213-8587(20)30234-5.
8
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):669. doi: 10.1016/S2213-8587(20)30235-7.
9
Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.).对辛格和辛格针对文章《糖尿病与2019冠状病毒病的死亡率及严重程度相关吗？一项荟萃分析》（库马尔等人著）所写信件的回复
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1147-1148. doi: 10.1016/j.dsx.2020.07.002. Epub 2020 Jul 8.
10
Pediatric Coronavirus Disease-19 (COVID-19): Meta-analyzing Literature Versus Natural History: Authors' Reply.儿童冠状病毒病-19（COVID-19）：文献荟萃分析与自然史：作者回复
Indian Pediatr. 2020 Sep 15;57(9):870. doi: 10.1007/s13312-020-1978-4.

引用本文的文献

1
Gut microbiota in post-acute COVID-19 syndrome: not the end of the story.新冠后急性综合征中的肠道微生物群：故事尚未结束。
Front Microbiol. 2024 Dec 24;15:1500890. doi: 10.3389/fmicb.2024.1500890. eCollection 2024.
2
Long-COVID, Metabolic and Endocrine Disease.长新冠、代谢与内分泌疾病。
Horm Metab Res. 2022 Aug;54(8):562-566. doi: 10.1055/a-1878-9307. Epub 2022 Jun 20.
3
Increased Incidence of Pediatric Diabetic Ketoacidosis After COVID-19: A Two-Center Retrospective Study in Korea.新冠疫情后韩国儿童糖尿病酮症酸中毒发病率上升：一项两中心回顾性研究
Diabetes Metab Syndr Obes. 2021 Feb 22;14:783-790. doi: 10.2147/DMSO.S294458. eCollection 2021.

本文引用的文献

1
Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis.2型糖尿病作为COVID-19严重程度的主要危险因素：一项荟萃分析。
Arch Endocrinol Metab. 2020 May-Jun;64(3):199-200. doi: 10.20945/2359-3997000000256.
2
New-Onset Diabetes in Covid-19.新冠病毒感染引发的新发糖尿病
N Engl J Med. 2020 Aug 20;383(8):789-790. doi: 10.1056/NEJMc2018688. Epub 2020 Jun 12.
3
Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease.PPAR-γ 药理学（或合成）激动剂和营养激动剂作为 COVID-19 疾病细胞因子风暴调节的候选物。
Molecules. 2020 Apr 29;25(9):2076. doi: 10.3390/molecules25092076.
4
Practical recommendations for the management of diabetes in patients with COVID-19.关于 COVID-19 患者糖尿病管理的实用建议。
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550. doi: 10.1016/S2213-8587(20)30152-2. Epub 2020 Apr 23.
5
Endocrine and metabolic link to coronavirus infection.内分泌和代谢与冠状病毒感染的关联。
Nat Rev Endocrinol. 2020 Jun;16(6):297-298. doi: 10.1038/s41574-020-0353-9.
6
Newly diagnosed and previously known diabetes mellitus and short-term outcomes in patients with acute myocardial infarction.急性心肌梗死患者新诊断及既往已知的糖尿病与短期预后
Coron Artery Dis. 2013 Dec;24(8):669-75. doi: 10.1097/MCA.0000000000000036.

Management of diabetes in patients with COVID-19 - Authors' reply.

作者信息

Bornstein Stefan R, Zimmet Paul, Rubino Francesco, Ludwig Barbara

机构信息

Department of Medicine III and Paul Langerhans Institute Dresden, Helmholtz Center Munich, University Hospital Carl Gustav Carus, Dresden, Germany; Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK; Department of Endocrinology and Diabetology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, Technische Universität Dresden, Dresden, Germany; German Center for Diabetes Research, Neuherberg, Germany.

Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.

出版信息

Lancet Diabetes Endocrinol. 2020 Aug;8(8):669-670. doi: 10.1016/S2213-8587(20)30223-0.

DOI:10.1016/S2213-8587(20)30223-0
PMID:32707113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7373385/
Abstract
摘要